Genentech updated its contract pharmacy restrictions to impose new claims data submissions and prevent covered entities from shipping 340B drugs to other locations through “alternate distribution models” or other channels.
Genentech Tightens Contract Pharmacy Restrictions to Require Hospital Claims Data, Targets 340B Drug Redistribution; 340B Lawyer Pushes Back
A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
